These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists. Szpakowska M; Meyrath M; Reynders N; Counson M; Hanson J; Steyaert J; Chevigné A Biochem Pharmacol; 2018 Jul; 153():299-309. PubMed ID: 29530506 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3. Zarca AM; Adlere I; Viciano CP; Arimont-Segura M; Meyrath M; Simon IA; Bebelman JP; Laan D; Custers HGJ; Janssen E; Versteegh KL; Buzink MCML; Nesheva DN; Bosma R; de Esch IJP; Vischer HF; Wijtmans M; Szpakowska M; Chevigné A; Hoffmann C; de Graaf C; Zarzycka BA; Windhorst AD; Smit MJ; Leurs R Mol Pharmacol; 2024 Mar; 105(4):301-312. PubMed ID: 38346795 [TBL] [Abstract][Full Text] [Related]
13. Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3. Szpakowska M; Nevins AM; Meyrath M; Rhainds D; D'huys T; Guité-Vinet F; Dupuis N; Gauthier PA; Counson M; Kleist A; St-Onge G; Hanson J; Schols D; Volkman BF; Heveker N; Chevigné A Br J Pharmacol; 2018 May; 175(9):1419-1438. PubMed ID: 29272550 [TBL] [Abstract][Full Text] [Related]
14. The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3. Wedemeyer MJ; Mahn SA; Getschman AE; Crawford KS; Peterson FC; Marchese A; McCorvy JD; Volkman BF J Biol Chem; 2020 Oct; 295(40):13927-13939. PubMed ID: 32788219 [TBL] [Abstract][Full Text] [Related]
15. The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides. Meyrath M; Szpakowska M; Zeiner J; Massotte L; Merz MP; Benkel T; Simon K; Ohnmacht J; Turner JD; Krüger R; Seutin V; Ollert M; Kostenis E; Chevigné A Nat Commun; 2020 Jun; 11(1):3033. PubMed ID: 32561830 [TBL] [Abstract][Full Text] [Related]
16. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin. Saaber F; Schütz D; Miess E; Abe P; Desikan S; Ashok Kumar P; Balk S; Huang K; Beaulieu JM; Schulz S; Stumm R Cell Rep; 2019 Feb; 26(6):1473-1488.e9. PubMed ID: 30726732 [TBL] [Abstract][Full Text] [Related]
17. Ackr3-Venus knock-in mouse lights up brain vasculature. Ehrlich AT; Semache M; Couvineau P; Wojcik S; Kobayashi H; Thelen M; Gross F; Hogue M; Le Gouill C; Darcq E; Bouvier M; Kieffer BL Mol Brain; 2021 Sep; 14(1):151. PubMed ID: 34583741 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding. Gustavsson M; Dyer DP; Zhao C; Handel TM Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506383 [TBL] [Abstract][Full Text] [Related]
19. Atypical chemokine receptor 3 induces colorectal tumorigenesis in mice by promoting β-arrestin-NOLC1-fibrillarin-dependent rRNA biogenesis. Yang J; Miao RR; Li YN; Pan T; Wu SH; Qu XJ; Cui SX Acta Pharmacol Sin; 2022 Nov; 43(11):2967-2976. PubMed ID: 35365782 [TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7. Szpakowska M; Dupuis N; Baragli A; Counson M; Hanson J; Piette J; Chevigné A Biochem Pharmacol; 2016 Aug; 114():14-21. PubMed ID: 27238288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]